Pregnancy in the Woman with Epilepsy: Maternal and Fetal Outcomes

Page B. Pennell

doi:10.1055/s-2002-36649

Seminars in Neurology, Table of Contents

Semin Neurol 2002; 22(3): 299-308
DOI: 10.1055/s-2002-36649

Pregnancy in the Woman with Epilepsy: Maternal and Fetal Outcomes

Page B. Pennell

Emory Epilepsy Monitoring Unit, Emory University School of Medicine, Atlanta, Georgia

Abstract

ABSTRACT

Pregnancy in women with epilepsy is associated with increased obstetric risks and increased adverse neonatal outcomes. Prior to conception, folic acid should be administered and the antiepileptic drug (AED) regimen should be optimized. Effective control of maternal seizures with the least risk to the fetus is the goal, preferably using AED monotherapy. Periodic monitoring of total and free AED levels is recommended. The "fetal anticonvulsant syndrome" has been described with all of the AEDs and includes major malformations, minor anomalies, microcephaly, cognitive impairment, intrauterine growth retardation, and infant mortality. The most common major malformations are cleft lip/palate, heart defects, and neural tube defects. Prenatal screening should be offered. Supplemental vitamin K₁ should be given to the mother and newborn to prevent neonatal hemorrhagic disorder. Careful planning and management of any pregnancy in women with epilepsy are essential to increase the likelihood of a healthy outcome for the mother and infant.

KEYWORD

Epilepsy - women - pregnancy - anticonvulsants - teratogenesis

Full Text

References

REFERENCES

1 Yerby M S. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology . 2000; 55(5 suppl 1) S21-S58
2 Janz D, Schmidt D. Anti-epileptic drugs and failure of oral contraceptives [letter]. Lancet . 1974; 1 1113
3 Guberman A. Hormonal contraception and epilepsy. Neurology . 1999; 53 (suppl 1) S38-S40
4 Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Neurology . 1998; 51 944-948
5 Morrell M J, Sarto G E, Shafer P O, Borda E A, Herzog A, Callanan M. Health issues for women with epilepsy: a descriptive survey to assess knowledge and awareness among healthcare providers. J Womens Health Gend Based Med . 2000; 9 959-965
6 Krauss G, Brandt J, Campbell M, Plate C, Summerfield M. Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians. Neurology . 1996; 46 1534-1539
7 Crawford P, Lee P. Gender differences in management of epilepsy: what women are hearing. Seizure . 1999; 8 135-139
8 Seale C, Morrell M, Nelson L, Druzin M. Analysis of prenatal and gestational care given to women with epilepsy. Neurology . 1998; 51 1039-1045
9 Fairgrieve S D, Jackson M, Jonas P. Population based, prospective study of the care of women with epilepsy in pregnancy. Br Med J . 2000; 321 674-675
10 Devinsky O, Yerby M. Women with epilepsy. Neurol Clin . 1994; 12 479-495
11 Cantrell D. Epilepsy and pregnancy: a study of seizure frequency and patient demographics. Epilepsia . 1997; 38 (suppl 8) 231
12 Yerby M, Collins S. Pregnancy and the mother. In: Engel J, Pedley T, eds. Epilepsy, a Comprehensive Textbook Philadelphia: Lippincott-Raven 1997: 2027-2035
13 Schmidt D, Canger R, Avanzini G. Change of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiatry . 1983; 46 751-755
14 Stumpf D, Frost M. Seizures, anticonvulsants, and pregnancy. Am J Dis Child . 1978; 132 746-748
15 Zahn C A, Morrell M J, Collins S D, Labiner D M, Yerby M S. Management issues for women with epilepsy: a review of the literature. Neurology . 1998; 51 949-956
16 Teramo K, Hiilesmaa V. Pregnancy and fetal complications in epileptic pregnancies: review of the literature. In: Janz D, Bossi L, Dam M, eds. Epilepsy, Pregnancy and the Child New York: Raven Press 1982: 53-59
17 Teramo K, Hiilesmaa V, Bardy A. Fetal heart rate during a maternal grand mal epileptic seizure. J Perinat Med . 1979; 7 3-5
18 Lindhout D, Meinardi H, Meijer J, Nau H. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology . 1992; 42 (suppl 5) 94-110
19 Samrén E, van Duijn C, Koch S. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia . 1997; 38 981-990
20 Nei M, Daly S, Liporace J. A maternal complex partial seizure in labor can affect fetal heart rate. Neurology . 1998; 51 904-906
21 Yerby M, Devinsky O. Epilepsy and pregnancy. In: Devinsky O, Feldmann E, Hainline B, eds. Advances in Neurology: Neurological Complications of Pregnancy New York: Raven Press 1994: 45-63
22 Pearlman M, Tintinalli J, Lorenz R. Blunt trauma during pregnancy. N Engl J Med . 1990; 323 1609-1613
23 Pennell P, Gleba J, Clements S. Antiepileptic drug monitoring during pregnancy in women with epilepsy. Epilepsia . 2000; 41 (suppl 7) 200
24 Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate and during lactation. Epilepsia . 2000; 41 709-713
25 Yerby M S. The use of anticonvulsants during pregnancy. Semin Perinatol . 2001; 25 153-158
26 Sathanandar S, Blesi K, Tran T, Leppik I. Lamotrigine clearance increases markedly during pregnancy. Epilepsia . 2000; 26 (suppl 1) 246
27 Levy R, Yerby M. Effects of pregnancy on antiepileptic drug utilization. Epilepsia . 1985; 26 (suppl 1) S52-S57
28 Yerby M, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia . 1985; 26 631-635
29 Hvas C, Henriksen T, Ostergaard J, Dam M. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. Br J Obstet Gynaecol . 2000; 107 896-902
30 Yerby M, Collins S. Teratogenicity of antiepileptic drugs. In: Engel J, Pedley T, eds. Epilepsy, a Comprehensive Textbook Philadelphia: Lippincott-Raven 1997: 1195-1203
31 Gilmore J, Pennell P B, Stern B J. Medication use during pregnancy for neurologic conditions. In: Evans R, ed. Neurologic Clinics: Iatrogenic Disorders Philadelphia: WB Saunders 1998: 189-206
32 Arpino C, Brescianini S, Robert E. Teratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposure (MADRE). Epilepsia . 2000; 41 1436-1443
33 Wide K, Winbladh B, Tomson T, Kallen B. Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years. Epilepsia . 2000; 41 854-861
34 Morrell M. Guidelines for the care of women with epilepsy. Neurology . 1998; 51 (suppl 5) S21-S27
35 Kaneko S, Battino D, Andermann E. Congenital malformations due to antiepileptic drugs. Epilepsy Res . 1999; 33 145-158
36 Lindhout D, Omtzigt J, Cornel M. Spectrum of neural-tube defects in 34 infants perinatally exposed to antiepileptic drugs. Neurology . 1992; 42 (suppl 5) 111-118
37 Rosa F. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med . 1991; 324 674-677
38 Lindhout D, Schmidt D. In-utero exposure to valproate and neural tube defects. Lancet . 1986; 2 1392-1393
39 Samrén E, van Duijn C, Christiaens G, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol . 1999; 46 739-746
40 Canger R, Battino D, Canevini M P. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia . 1999; 40 1231-1236
41 Yerby M, Cawthon M. Fetal death, malformations and infant mortality in infants of mothers with epilepsy. Epilepsia . 1996; 37 (suppl 5) 98
42 Howe A, Oakes D, Woodman P, Webster W. Prothrombin and PIVKA-II levels in cord blood from newborn exposed to anticonvulsants during pregnancy. Epilepsia . 1999; 40 980-984
43 Srinivasan G, Seeler R A, Tiruvury A. Maternal anticonvulsant therapy and hemorrhagic disease of the newborn. Obstet Gynecol . 1982; 59 250-252
44 Nelson K B, Ellenber J H. Maternal seizure disorder, outcomes of pregnancy, and neurologic abnormalities in the children. Neurology . 1982; 32 1247-1254
45 Ganström M, Gaily E. Psychomotor development in children of mothers with epilepsy. Neurology . 1992; 42 (suppl 5) 144
46 Leonard G, Andermann E, Ptito A. Cognitive effects of antiepileptic drug therapy during pregnancy on school-age offspring. Epilepsia . 1997; 38 (suppl 3) 170
47 Meador K. Cognitive effects of epilepsy and of antiepileptic medications. In: Wyllie E, ed. The Treatment of Epilepsy: Principles and Practice 3rd ed. Philadelphia: Williams & Wilkins 2001: 1215-1226
48 Leavitt A, Yerby M, Robinson N, Sells C, Erickson D. Epilepsy in pregnancy: developmental outcome of offspring at 12 months. Neurology . 1992; 42(4 suppl 5) 141-143
49 Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry . 2001; 70 15-21
50 Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh J. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol . 2001; 43 202-206
51 Koch S, Titze K, Zimmerman R, Schroder M, Lehmkuhl U, Rauh H. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia . 1999; 40 1237-1243
52 Reinisch J, Sanders S, Mortensen E, Rubin D. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA . 1995; 724 1518-1525
53 Vanoverloop D, Schnell R, Harvey E, Holmes L. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol . 1992; 14 329-335
54 Battino D, Kaneko S, Andermann E. Intrauterine growth in the offspring of epileptic women: a prospective multicenter study. Epilepsy Res . 1999; 36 53-60
55 Annegers J, Hauser W, Elveback L, Anderson V, Kurland L. Congenital malformations and seizure disorders in the offspring of parents with epilepsy. Int J Epidemiol . 1978; 7 241-247
56 Ottman R, Annegers J, Hauser W, Kurland L. Higher risk of seizures in offspring of mothers than fathers with epilepsy. Am J Hum Genet . 1988; 43 357-364
57 Holmes L B, Harvey E A, Coull B A. The teratogenicity of anticonvulsant drugs. N Engl J Med . 2001; 344 1132-1138
58 Holmes L B, Rosenberger P B, Harvey E A, Khoshbin S, Ryan L. Intelligence and physical features of children of women with epilepsy. Teratology . 2000; 61 196-202
59 Delgado-Escueta A, Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology . 1992; 42 149-160
60 Holmes L, Lieberman E. Report of first positive findings from hospital-based AED pregnancy registry. Teratology . 2001; 63 250
61 GlaxoSmithKline. Lamotrigine pregnancy registry, interim report, 9/1/92-3/30/01; 2001 .
62 Dansky L, Rosenblatt D, Andermann E. Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology . 1992; 42 32-42
63 Wegner C, Nau H. Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanisms of teratogenesis. Neurology . 1992; 42 (suppl 5) 17-24
64 Botto L, Moore C, Khoury M, Erickson J. Medical progress: neural-tube defects. N Engl J Med . 1999; 341 1509-1519
65 MRC Vitamin Study Research Group. Prevention of neural-tube defects: results of the Medical Research Council Vitamin Study. Lancet . 1991; 338 131-137
66 Hall J, Solehdin F. Folic acid for the prevention of congenital anomalies. Eur J Pediatr . 1998; 157 445-450
67 Crawford P. CPD-education and self-assessment: epilepsy and pregnancy. Seizure . 2001; 10 212-219
68 American College of Obstetricians and Gynecologists. Seizure disorders in pregnancy. ACOG Education Bulletin. 1996; No 231
69 Buehler B A, Rao V, Finnell R H. Biochemical and molecular teratology of fetal hydantoin syndrome. Pediatr Neurogenet . 1994; 12 741-748
70 Pschirrer E, Monga M. Seizure disorders in pregnancy. Obstet Gynecol Clin . 2001; 28 601-611
71 Malone F, D'Alton M. Drugs in pregnancy: anticonvulsants. Semin Perinatol . 1997; 21 114-123
72 Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. Seizure disorders in pregnancy. Int J Gynecol Obstet . 1997; 56 279-286
73 Krauer B, Krauer F. Drug kinetics in pregnancy. Clin Pharmacokinet . 1977; 2 167-181
74 Fox C, Betts T. How much risk does a woman with active epilepsy pose to her newborn child in the puerperium?. <~>A pilot study. Seizure . 1999; 86 367-369
75 Hale T. Medications and Mothers' Milk. 8th ed. Amarillo, TX: Pharmasoft Medical Publishing; 1999
76 Moore K. The Developing Human: Clinically Oriented Embryology. 4th ed. Philadelphia: WB Saunders; 1988